Navigation Links
Genedata Screener Global User Group Meetings Will Examine Advancements in Plate-based Screening
Date:9/4/2013

Basel, Switzerland (PRWEB) September 04, 2013

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that four Genedata Screener User Group Meetings will be held in Asia, Europe, and North America during September 2013. Annual global meetings bring together scientists, lab heads, bioinformaticians, and research IT managers from leading pharmaceutical and biotechnology companies, academic institutions, and contract research organizations. With more than half of the top 25 pharmaceutical companies using Genedata Screener, industry experts from AstraZeneca, Eli Lilly, and Vertex Pharmaceuticals will be among the featured speakers who represent a growing community of researchers who run screening experiments for Compound Combination, Ion Channel, high-throughput screening, high-content screening, and label-free data analysis.

“Genedata Screener User Group Meetings underscore one of the core values at Genedata – namely that of collaboration,” said Dr. Othmar Pfannes, CEO of Genedata. “They provide real-life opportunities for Screener users to meet their peers, learn, share experiences, and discover more applications for Genedata Screener. This level of global collaboration fuels continuous technology innovations from Genedata.”

The 2013 Genedata Screener User Group Meetings will also feature Best Practice sessions on topics such as “Feature Selection in HCS Assays” and “Compound Profiling with Hit Profiler.” Meetings will be held in: Tokyo, Japan (Sept. 3); Basel, Switzerland (Sept. 10); Boston, MA (Sept.17); and San Francisco, CA (Sept. 19). Inquiries may be sent to: ugm(at)genedata(dot)com.

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. http://www.genedata.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11083970.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genedata Screener Extends Support for High-Throughput Thermofluor Assays
2. Genedata at ESACT Announces Expansion Into Biopharma Process Development
3. New Genedata Expressionist for Mass Spectrometry Showcases at 2013 ASMS
4. AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization
5. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
6. Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 2013
7. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
8. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
9. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
10. Genedata Biologics 3.0 Boosts Efficiency Through Standardization
11. Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... - New FDA action date of July ... action date of July 22, 2016   --> ... 22, 2016   - Lifitegrast has the ... for the treatment of signs and symptoms of dry eye disease ... to be the only product approved in the U.S. in the past decade indicated for ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... takes place February 5-6 at the University’s student center, Kehr Union, located ... as workshops and competitions for ample networking, learning and collaborating opportunities. , ...
(Date:2/4/2016)... MENLO PARK, Calif. , Feb. 4, 2016   ... a biopharmaceutical company focused on the development and commercialization of ... the 18 th Annual BIO CEO & Investor ... EST in New York, NY . ... provide an update on the ongoing clinical trial of ...
(Date:2/4/2016)... 2016  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual ... of intellectual property, today provided an update on the ... District of Texas and announcing ... Inter Partes Re-examination ("IPR") proceedings that VTech and ... was initiated on only certain claims of two of ...
Breaking Biology Technology:
(Date:1/25/2016)... 2016   Unisys Corporation (NYSE: UIS ) today ... (JFK) International Airport, New York City , to ... attempting to enter the United States using ... pilot testing of the system at Dulles last year. ... JFK during January 2016. --> pilot testing of ...
(Date:1/22/2016)... 22, 2016 ... the "Global Biometrics Market in Retail ... --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has ... Biometrics Market in Retail Sector 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ...
(Date:1/20/2016)... MINNETONKA, Minn. , Jan. 20, 2016   ... that supports the entire spectrum of clinical research, is ... in 2015. MedNet,s significant achievements are the result of ... of) iMedNet eClinical , it,s comprehensive, ... --> --> Key MedNet growth ...
Breaking Biology News(10 mins):